Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/30/2025

Diagnostic Approach for Herpes Simplex Encephalitis

  • The American College of Radiology recommends MRI (including diffusion-weighted imaging) as the preferred imaging modality for suspected encephalitis cases, which should be performed within 24-48 hours of hospital admission for all patients 1, 2
  • Early MRI changes in HSE occur in the cingulate gyrus and medial temporal lobe, showing gyral edema on T1-weighted images and high signal intensity on T2-weighted and FLAIR images, with an approximate sensitivity of 90% within 48 hours of hospital admission 1
  • Diffusion-weighted MRI may be especially sensitive for detecting early changes in HSE, with a higher sensitivity compared to CT scanning 1
  • The Infectious Diseases Society of America recommends that if the patient's condition precludes an MRI, urgent CT scanning may be used to exclude structural causes of raised intracranial pressure or reveal alternative diagnoses, although CT has limited sensitivity of about 25% for initial HSE diagnosis 1, 2

Diagnostic Gold Standard

  • The Centers for Disease Control and Prevention consider CSF PCR for HSV DNA as the diagnostic gold standard for HSE, with a high sensitivity and specificity 3, 4
  • However, CSF PCR can occasionally be negative in HSE, especially if performed early (<72 hours after symptom onset) or late in the illness, with a reported false-negative rate 4

Treatment Considerations

  • The Infectious Diseases Society of America recommends intravenous aciclovir (10 mg/kg three times daily) to be started if initial CSF and/or imaging findings suggest viral encephalitis, or within 6 hours of admission if these results will not be available, with a treatment duration of 14-21 days in confirmed HSE cases 3, 4, 5, 6

Common Pitfalls to Avoid

  • The American Academy of Neurology advises against relying on a single negative CSF PCR to rule out HSE, as false negatives can occur, and against delaying treatment while waiting for imaging or laboratory confirmation, which is associated with increased mortality and morbidity 1, 4, 5
  • The American College of Radiology recommends against using CT as the only imaging modality, as CT has poor sensitivity for early HSE changes 1

Temporal Lobe Involvement in HSV Encephalitis

Imaging Manifestations

  • FDG-PET demonstrates regions of hypermetabolism most frequently in the medial temporal lobes in HSV encephalitis, which may reflect seizure activity. 7, 8, 9, 10

  • The temporal lobe involvement is characteristic and helps distinguish HSV encephalitis from other viral encephalitides and non-infectious conditions. 7

Clinical Consequences

  • Temporal lobe spike-and-wave activity and periodic lateralized epileptiform discharges (PLEDs) occur in many cases of HSV encephalitis, reflecting the temporal focus of infection. 7, 8, 9

  • Temporal lobe seizures are relatively frequent as a direct consequence of the anatomical distribution in HSV encephalitis. 11, 12

  • Memory deficits and neuropsychiatric sequelae occur in 20-60% of survivors of HSV encephalitis, reflecting damage to hippocampal and limbic structures. 13, 11

Pathophysiological Basis

  • Autopsy studies reveal hippocampal disease with HHV-6 protein in astrocytes and neurons, suggesting local virus reactivation in these specific anatomical structures. 11, 12

  • The virus demonstrates specific involvement of areas such as the entorhinal cortex and amygdala, which are integral components of the temporal lobe limbic system. 11, 12

Differential Diagnosis

  • Japanese B encephalitis typically involves thalamus and basal ganglia, while enterovirus may predominantly affect the brainstem, distinguishing these from HSV encephalitis. 14, 15

  • CT scanning has only 25% sensitivity for initial HSV encephalitis diagnosis, and even MRI may be negative at disease onset. 14, 15

Diagnosis and Treatment of Herpes Simplex Encephalitis

Diagnostic Approach

  • The American Academy of Neurology recommends that all patients with suspected encephalitis undergo PCR testing in cerebrospinal fluid (CSF) for HSV-1, HSV-2, and VZV, as this will identify 90% of known viral cases 16, 17
  • The PCR test for HSV in CSF has a sensitivity and specificity of over 95% when performed between days 2 and 10 of the disease, according to the Infectious Diseases Society of America 16, 18
  • The initial analysis of CSF should include basic parameters, such as opening pressure, total and differential leukocyte count, erythrocyte count, protein, and glucose, as recommended by the American Academy of Neurology 16, 17
  • Additional PCR tests for enterovirus and parechovirus should be performed in all patients, as suggested by the American Academy of Pediatrics 16, 17

Treatment Approach

  • The Infectious Diseases Society of America recommends that intravenous aciclovir be started immediately in all patients with suspected encephalitis, as soon as possible and without waiting for diagnostic results 18
  • The dosage of aciclovir is 10 mg/kg IV every 8 hours for adults and children over 12 years, as recommended by the American Academy of Neurology 18
  • The treatment should be continued for 14-21 days for confirmed HSV encephalitis, according to the Infectious Diseases Society of America 18
  • Early treatment initiation is crucial, as it reduces the probability of death or severe sequelae, with a mortality rate of 28% at 18 months even with treatment, as reported by the American Academy of Neurology 18

Special Considerations

  • In immunocompromised patients, additional tests such as PCR for CMV, HHV-6/7, and HIV should be considered, as recommended by the Infectious Diseases Society of America 16, 17
  • The dosage of aciclovir may need to be adjusted in patients with renal insufficiency, with close monitoring of renal function and hydration to prevent crystaluria and obstructive nephropathy, as suggested by the American Academy of Neurology 16

Herpes Simplex Encephalitis Diagnosis

Diagnostic Approaches

  • The European consensus statement recommends testing cerebrospinal fluid (CSF) for both PCR and antibody detection, as a negative HSV-PCR result with a negative HSV-specific CSF antibody test 10-14 days after symptom onset can effectively rule out the disease 19, 20
  • Intrathecal synthesis of HSV-specific IgG antibodies can support the diagnosis of HSV encephalitis in CSF samples taken 10-12 days after symptom onset 19, 20
  • The detection of virus-specific IgM in CSF indicates an intrathecal antiviral immune response, which is particularly useful for flaviviruses and other RNA viruses 19, 20
  • Acute and convalescent blood samples should be taken for appropriate serological tests based on specific epidemiological and clinical features 19, 20

Interpretation of Test Results

  • A single negative CSF PCR result is not sufficient to rule out HSV encephalitis, especially if taken less than 72 hours after symptom onset or during the late stage of the disease 19, 21
  • If clinical suspicion is high, a second lumbar puncture should be performed 24-48 hours after the initial negative PCR result 21, 22
  • Two negative CSF PCR results make HSV encephalitis unlikely, but treatment should be continued if clinical suspicion remains high 21

Laboratory Findings

  • Oligoclonal band detection in CSF is a non-specific indicator of an inflammatory process, while immunoblotting for anti-HSV antibodies can be used for diagnosis 19, 23

Herpes Simplex Encephalitis Diagnosis and Treatment

Diagnostic Approach

  • The American Academy of Neurology recommends that PCR has a sensitivity and specificity of over 95% for detecting HSV DNA in cerebrospinal fluid (CSF), and is most reliable when performed between 2-10 days after symptom onset 24
  • The Infectious Diseases Society of America suggests that intrathecal HSV-specific IgG antibody synthesis can support the diagnosis of HSE in CSF samples taken 10-12 days after symptom onset, with a strength of evidence rated as moderate 25

Treatment Approach

  • The European Society of Clinical Microbiology and Infectious Diseases recommends that intravenous aciclovir (10 mg/kg every 8 hours) should be started within 6 hours of admission if the initial CSF and/or imaging findings suggest viral encephalitis, or if the patient is in a severe condition or deteriorating 26, 27
  • The treatment should be continued for 14-21 days, as recommended by the Infectious Diseases Society of America, with a strength of evidence rated as high 24, 25

Prognostic Factors

  • The Infectious Diseases Society of America states that delayed treatment increases mortality and morbidity: if treatment is started within 4 days of symptom onset, mortality decreases to 8%, but increases to 28% if started after 4 days, with a strength of evidence rated as moderate 25
  • Even with aciclovir treatment, mortality at 18 months is 25-28%, and 20-60% of survivors develop neurological sequelae, as reported by the Infectious Diseases Society of America, with a strength of evidence rated as moderate 25

REFERENCES

← Return to Home